Tiantian Wu

836 citations
19 papers · 695 indexed · 1 hit paper · h-index 10

Tiantian Wu

17 papers receiving 693 citations

Hit Papers

A DNA nanodevice-based vaccine for cancer immunotherapy4432020202620222024100200300400

Peers

Tiantian Wu
Comparison fields: 5 of 77
  • Immunology 216
  • Molecular Biology 425
  • Biomedical Engineering 239
  • Biomaterials 67
  • Oncology 79
Replace Jianghua Yan with:
Jianghua Yan China
Lele Sun China
Elise Robinson United States
Ajay S. Thatte United States
Tiffany L. Halo United States
Marleen H. M. E. van Stevendaal Netherlands
Surya Murty United States
Alexander L. Watters United States
Diego A. Pantano United States
Carine Pestourie France
Tiantian Wu relative to Jianghua Yan China Jianghua Yan's profile →
Citations per field
00.5×1.5×2.1×
Jianghua Yan · 1×
Citations per year

Countries citing papers authored by Tiantian Wu

Since Specialization
Citations

This map shows the geographic impact of Tiantian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiantian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiantian Wu more than expected).

Fields of papers citing papers by Tiantian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiantian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiantian Wu. The network helps show where Tiantian Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tiantian Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tiantian Wu Line = papers co-authored together Tiantian Wu links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20250
2 20250
3 20241
4 20243
5 20242
6
A DNA nanodevice-based vaccine for cancer immunotherapybreakdown →
2020443
7 202015
8 20202
9 20197
10 20191
11 20196
12 201923
13 201945
14 201918
15 201854
16 201812
17 201812
18 201716
19 201435

About Tiantian Wu

Tiantian Wu is a scholar working on Developmental Neuroscience, Pharmaceutical Science and Biomaterials, having authored 19 papers that have together received 695 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (7 papers), RNA Interference and Gene Delivery (6 papers), Bone Tissue Engineering Materials (2 papers), Molecular Sensors and Ion Detection (2 papers), Boron and Carbon Nanomaterials Research (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Immunotherapy and Immune Responses (2 papers) and Luminescence and Fluorescent Materials (2 papers). The work is most often cited by research in Immunology (216 citations), Molecular Biology (425 citations) and Biomedical Engineering (239 citations). Tiantian Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Guangjun Nie, Yingxu Shang, Baoquan Ding, Yinlong Zhang, Jianbing Liu, Xiao Zhao, Ruifang Zhao, Yuanning Wang, Qiao Jiang and Shuai Zhao. Their work appears in journals such as Nature Materials, Chemical Communications and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026